The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
A more comprehensive management approach is needed to tackle the rising threat of diabetes in the region.
Designers and manufacturers of both devices and software must conduct due diligence and ensure regulatory compliance in protecting user data.
Expanded designs that enable clinicians to leverage data in making healthcare decisions, but privacy challenges remain.
Personalized medicine is the future of healthcare, and artificial intelligence will play a big role.
Treatment can no longer be one dimensional.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.
The transition to digital in healthcare is happening at a fast pace.
Artificial intelligence and machine learning technologies have significant potential, but regulatory hurdles may stand in their way.
The revolution in data and technology should be pushing companies to focus on safeguarding intellectual property.